 Sara Johnson
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blueberry Plants | 3 | 2026 | 8 | 2.510 |
Why?
| | Gastrointestinal Microbiome | 8 | 2025 | 774 | 1.490 |
Why?
| | Military Personnel | 3 | 2022 | 737 | 1.210 |
Why?
| | Fruit | 3 | 2026 | 148 | 1.120 |
Why?
| | Cardiovascular Diseases | 3 | 2026 | 2185 | 1.060 |
Why?
| | Brassica | 1 | 2025 | 5 | 0.880 |
Why?
| | Beta vulgaris | 1 | 2025 | 14 | 0.870 |
Why?
| | Dietetics | 1 | 2023 | 24 | 0.780 |
Why?
| | Diet | 4 | 2025 | 1280 | 0.750 |
Why?
| | Mindfulness | 5 | 2023 | 155 | 0.730 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.710 |
Why?
| | Plaque, Atherosclerotic | 1 | 2022 | 61 | 0.700 |
Why?
| | Airway Management | 1 | 2022 | 82 | 0.670 |
Why?
| | Polyphenols | 3 | 2026 | 21 | 0.640 |
Why?
| | Military Medicine | 1 | 2022 | 148 | 0.630 |
Why?
| | Virion | 2 | 2017 | 111 | 0.620 |
Why?
| | Atherosclerosis | 1 | 2022 | 410 | 0.560 |
Why?
| | Hypertension | 2 | 2023 | 1273 | 0.510 |
Why?
| | Anthocyanins | 3 | 2026 | 31 | 0.480 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2011 | 419 | 0.480 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 461 | 0.470 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 445 | 0.450 |
Why?
| | Nuclear Proteins | 2 | 2011 | 743 | 0.440 |
Why?
| | Emergency Medical Services | 1 | 2021 | 697 | 0.400 |
Why?
| | RNA, Messenger | 3 | 2024 | 2820 | 0.380 |
Why?
| | Tourniquets | 2 | 2022 | 34 | 0.340 |
Why?
| | RNA, Fungal | 1 | 2011 | 73 | 0.340 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 93 | 0.330 |
Why?
| | Blood Transfusion | 3 | 2022 | 408 | 0.310 |
Why?
| | Phenols | 2 | 2023 | 107 | 0.300 |
Why?
| | RNA 3' End Processing | 1 | 2008 | 11 | 0.290 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2582 | 0.290 |
Why?
| | Insulin Resistance | 3 | 2022 | 1244 | 0.290 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 28 | 0.290 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2024 | 265 | 0.270 |
Why?
| | Humans | 29 | 2026 | 145491 | 0.270 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 580 | 0.250 |
Why?
| | Mental Health | 2 | 2025 | 795 | 0.250 |
Why?
| | Feces | 3 | 2025 | 514 | 0.240 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2026 | 16 | 0.240 |
Why?
| | Double-Blind Method | 4 | 2025 | 2060 | 0.240 |
Why?
| | Gastrointestinal Tract | 2 | 2021 | 208 | 0.240 |
Why?
| | Hemorrhage | 2 | 2022 | 826 | 0.230 |
Why?
| | Malus | 1 | 2025 | 12 | 0.230 |
Why?
| | Cross-Over Studies | 2 | 2025 | 607 | 0.230 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2025 | 23 | 0.230 |
Why?
| | Flavonoids | 1 | 2026 | 86 | 0.230 |
Why?
| | Gastrointestinal Diseases | 2 | 2025 | 221 | 0.220 |
Why?
| | Microalgae | 1 | 2025 | 10 | 0.220 |
Why?
| | Lupus Nephritis | 1 | 2025 | 67 | 0.220 |
Why?
| | Sambucus | 1 | 2024 | 1 | 0.220 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 108 | 0.220 |
Why?
| | Fruit and Vegetable Juices | 1 | 2024 | 21 | 0.210 |
Why?
| | Precision Medicine | 2 | 2025 | 456 | 0.210 |
Why?
| | Postmenopause | 2 | 2023 | 391 | 0.200 |
Why?
| | Powders | 1 | 2023 | 44 | 0.190 |
Why?
| | Dietary Supplements | 2 | 2025 | 580 | 0.190 |
Why?
| | Mice, Knockout, ApoE | 1 | 2022 | 11 | 0.190 |
Why?
| | Plasma | 2 | 2022 | 225 | 0.190 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2026 | 673 | 0.180 |
Why?
| | Fatty Acids | 2 | 2023 | 459 | 0.180 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 163 | 0.180 |
Why?
| | Apolipoproteins E | 1 | 2022 | 94 | 0.180 |
Why?
| | Fragaria | 1 | 2021 | 2 | 0.180 |
Why?
| | Suction | 1 | 2022 | 32 | 0.180 |
Why?
| | Paired-Associate Learning | 1 | 2021 | 13 | 0.170 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 79 | 0.170 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2021 | 40 | 0.170 |
Why?
| | Touch | 1 | 2021 | 39 | 0.170 |
Why?
| | Ascorbic Acid | 1 | 2023 | 175 | 0.170 |
Why?
| | Cognitive Aging | 1 | 2021 | 18 | 0.170 |
Why?
| | Technology | 1 | 2022 | 95 | 0.170 |
Why?
| | Dietary Fats | 1 | 2023 | 308 | 0.170 |
Why?
| | Bulimia | 1 | 2020 | 35 | 0.160 |
Why?
| | Binge-Eating Disorder | 1 | 2020 | 30 | 0.160 |
Why?
| | Probiotics | 1 | 2021 | 61 | 0.160 |
Why?
| | Bacillus subtilis | 1 | 2021 | 70 | 0.160 |
Why?
| | Antigens | 1 | 2002 | 349 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2025 | 1119 | 0.160 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 165 | 0.160 |
Why?
| | Immunomodulation | 1 | 2021 | 99 | 0.160 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 187 | 0.160 |
Why?
| | Obesity | 6 | 2024 | 3076 | 0.150 |
Why?
| | Mentors | 1 | 2022 | 218 | 0.150 |
Why?
| | Animals | 11 | 2026 | 38141 | 0.150 |
Why?
| | Plant Extracts | 1 | 2021 | 188 | 0.150 |
Why?
| | Biomarkers | 4 | 2025 | 4283 | 0.150 |
Why?
| | Male | 17 | 2025 | 72817 | 0.150 |
Why?
| | Female | 17 | 2025 | 78763 | 0.150 |
Why?
| | Glucose Intolerance | 1 | 2021 | 142 | 0.150 |
Why?
| | Adult | 10 | 2025 | 40707 | 0.140 |
Why?
| | Blood Platelets | 1 | 2022 | 380 | 0.140 |
Why?
| | Mitochondrial Trifunctional Protein | 1 | 2018 | 5 | 0.140 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 573 | 0.140 |
Why?
| | Anion Exchange Resins | 1 | 2017 | 8 | 0.140 |
Why?
| | Behavior, Animal | 1 | 2021 | 526 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2021 | 252 | 0.130 |
Why?
| | Bone Density | 1 | 2021 | 484 | 0.130 |
Why?
| | Ammonium Sulfate | 1 | 2017 | 13 | 0.130 |
Why?
| | Virus Cultivation | 1 | 2017 | 31 | 0.130 |
Why?
| | Citrates | 1 | 2017 | 40 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 478 | 0.130 |
Why?
| | Biotechnology | 1 | 2017 | 46 | 0.130 |
Why?
| | Peromyscus | 1 | 2016 | 5 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4559 | 0.120 |
Why?
| | Ethinyl Estradiol | 1 | 2016 | 16 | 0.120 |
Why?
| | Neuropsychological Tests | 1 | 2021 | 1139 | 0.120 |
Why?
| | Students | 1 | 2022 | 658 | 0.120 |
Why?
| | Health Behavior | 1 | 2022 | 788 | 0.120 |
Why?
| | Endothelium, Vascular | 1 | 2023 | 951 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2023 | 1350 | 0.120 |
Why?
| | Blood Pressure | 1 | 2023 | 1782 | 0.120 |
Why?
| | Aging | 2 | 2008 | 1940 | 0.120 |
Why?
| | Benzhydryl Compounds | 1 | 2016 | 81 | 0.120 |
Why?
| | Bacteriophages | 1 | 2017 | 113 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 563 | 0.120 |
Why?
| | Signal Transduction | 2 | 2026 | 5202 | 0.110 |
Why?
| | Mice | 6 | 2025 | 18338 | 0.110 |
Why?
| | Inflammation | 2 | 2023 | 2883 | 0.110 |
Why?
| | United States | 2 | 2023 | 16115 | 0.100 |
Why?
| | Mutation | 1 | 2025 | 4093 | 0.100 |
Why?
| | Cognition | 1 | 2021 | 1268 | 0.090 |
Why?
| | Young Adult | 4 | 2025 | 14192 | 0.090 |
Why?
| | Adolescent | 8 | 2025 | 22485 | 0.090 |
Why?
| | Pilot Projects | 3 | 2025 | 1896 | 0.090 |
Why?
| | Healthy Volunteers | 2 | 2025 | 218 | 0.090 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2011 | 139 | 0.080 |
Why?
| | Hydrolysis | 1 | 2011 | 199 | 0.080 |
Why?
| | Middle Aged | 5 | 2025 | 36176 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1511 | 0.080 |
Why?
| | RNA, Untranslated | 1 | 2011 | 124 | 0.080 |
Why?
| | B-Lymphocytes | 2 | 2008 | 878 | 0.080 |
Why?
| | Bacteria | 1 | 2016 | 897 | 0.080 |
Why?
| | Autoimmunity | 2 | 2025 | 936 | 0.070 |
Why?
| | RNA Transport | 1 | 2008 | 27 | 0.070 |
Why?
| | Overweight | 2 | 2024 | 607 | 0.070 |
Why?
| | Risk Factors | 1 | 2023 | 10874 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2008 | 120 | 0.070 |
Why?
| | Weight Gain | 2 | 2023 | 557 | 0.070 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 161 | 0.070 |
Why?
| | Oxidation-Reduction | 2 | 2024 | 1080 | 0.070 |
Why?
| | Ribonucleoproteins | 1 | 2008 | 104 | 0.070 |
Why?
| | Child | 3 | 2022 | 22680 | 0.060 |
Why?
| | Aged | 2 | 2025 | 26125 | 0.060 |
Why?
| | Mice, Inbred C57BL | 3 | 2025 | 5989 | 0.060 |
Why?
| | Cellular Senescence | 1 | 2008 | 225 | 0.060 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 12 | 0.060 |
Why?
| | Food Analysis | 1 | 2025 | 24 | 0.060 |
Why?
| | Binding Sites | 1 | 2008 | 1313 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 50 | 0.060 |
Why?
| | Stress, Psychological | 2 | 2025 | 1153 | 0.050 |
Why?
| | Thymus Gland | 1 | 2026 | 311 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2008 | 419 | 0.050 |
Why?
| | Interleukin-15 | 1 | 2025 | 96 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2137 | 0.050 |
Why?
| | Ketone Bodies | 1 | 2024 | 15 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2910 | 0.050 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2024 | 17 | 0.050 |
Why?
| | Palmitates | 1 | 2024 | 21 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2025 | 440 | 0.050 |
Why?
| | Hyperphagia | 1 | 2023 | 38 | 0.050 |
Why?
| | Body Mass Index | 2 | 2021 | 2425 | 0.050 |
Why?
| | Immunoglobulin delta-Chains | 1 | 2002 | 2 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2021 | 17269 | 0.050 |
Why?
| | Immunoglobulin mu-Chains | 1 | 2002 | 8 | 0.050 |
Why?
| | Immunoglobulin Idiotypes | 1 | 2002 | 28 | 0.050 |
Why?
| | Liver | 2 | 2024 | 1895 | 0.050 |
Why?
| | Genes, Immunoglobulin | 1 | 2002 | 29 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2002 | 87 | 0.040 |
Why?
| | Lymphopenia | 1 | 2002 | 64 | 0.040 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2002 | 86 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 407 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2002 | 165 | 0.040 |
Why?
| | Bone Resorption | 1 | 2021 | 81 | 0.040 |
Why?
| | Conditioning, Operant | 1 | 2021 | 98 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2021 | 268 | 0.040 |
Why?
| | Afghan Campaign 2001- | 1 | 2022 | 193 | 0.040 |
Why?
| | Models, Biological | 1 | 2008 | 1815 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2021 | 33 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2002 | 320 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2002 | 282 | 0.040 |
Why?
| | Spleen | 1 | 2002 | 511 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 729 | 0.040 |
Why?
| | Video Recording | 1 | 2021 | 218 | 0.040 |
Why?
| | Parent-Child Relations | 1 | 2022 | 271 | 0.040 |
Why?
| | Universities | 1 | 2022 | 455 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6070 | 0.040 |
Why?
| | Mentoring | 1 | 2022 | 165 | 0.040 |
Why?
| | Up-Regulation | 1 | 2002 | 848 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 917 | 0.040 |
Why?
| | Parenting | 1 | 2022 | 319 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2002 | 1134 | 0.030 |
Why?
| | Chromatography, Ion Exchange | 1 | 2017 | 58 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 115 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 166 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2026 | 1996 | 0.030 |
Why?
| | Cell Movement | 1 | 2002 | 961 | 0.030 |
Why?
| | Sirtuin 3 | 1 | 2018 | 58 | 0.030 |
Why?
| | Kidney | 1 | 2025 | 1498 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2020 | 452 | 0.030 |
Why?
| | Acetylation | 1 | 2018 | 250 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1127 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2023 | 694 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2002 | 2189 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 264 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 518 | 0.030 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 470 | 0.030 |
Why?
| | Incidence | 1 | 2022 | 2915 | 0.030 |
Why?
| | Autoantibodies | 1 | 2002 | 1512 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2330 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2002 | 2045 | 0.030 |
Why?
| | Age Factors | 1 | 2021 | 3340 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 891 | 0.030 |
Why?
| | Parents | 1 | 2022 | 1404 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1706 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2054 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5581 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5426 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6437 | 0.020 |
Why?
| | Mitochondria | 1 | 2018 | 990 | 0.020 |
Why?
| | Depression | 1 | 2021 | 1573 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 8039 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 5992 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5891 | 0.020 |
Why?
| | Infant | 1 | 2023 | 10064 | 0.020 |
Why?
| | Lymphopoiesis | 1 | 2008 | 27 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2008 | 4127 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|